Advocates request that the South African Health Products Regulatory Authority expedite registration of essential medicines for the treatment and prevention of TB in South Africa.

Advocates request that bedaquiline become part of the standard treatment regimen for drug-resistant TB in India.

Representatives of communities affected by TB and civil society organizations formulate a civil society position on TB accountability, guided by the draft World Health Organization Accountability Framework.

Advocates highlight in a letter, addressed to the leadership of the United Nations High-Level Meeting on TB, key human rights commitments.

Advocates call on Indian Prime Minister to personally attend the UN High-Level Meeting on TB and lead the country’s national delegation.

Members of Parliament from from across the world gathered in New York on 24-27 April 2018 to increase political visibility and engagement as a lead up to the UN High-Level Meeting on TB in September this year.

Advocates call on WHO leadership to ensure rapid development of clear, consolidated guidelines for the diagnosis and treatment of TB.

Advocates urge PEPFAR to ensure that 2018 Country Operating Plans for all high TB/HIV burden countries include TB-LAM testing.

TB CAB issues a position statement on the use of bedaquiline as part of the preferred regimen for MDR-TB.

Kenyan advocates encourage Dr. Tedros to engage with civil society and communities in future country visits.